Heidelberg Pharma AG

Director's Dealing • Dec 11, 2009

News Details

Directors’ Dealings | 11 December 2009 17:03

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Company: dievini Hopp BioTech holding GmbH & Co. KG Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: share ISIN/WKN of the financial instrument: ISIN DE000A1A60 Type of transaction: purchase Date: 07.12.2009 Price: 4.10 Currency: EUR No. of items: 362869 Total amount traded: 1487762.90 Place: außerbörslich/OTC Explanation for publication: rump placement of unsubscribed shares(not registered shares) Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 11.12.2009 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 10584